Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. S-3 Offering Registration Statement
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. 424B5 Offering Prospectus
  6. 424B4 Offering Prospectus
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-1 Offering Registration Statement
  10. UPLOAD Other SEC-generated Letter
  11. 424B4 Offering Prospectus
  12. S-1/A Offering Registration Statement
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-1/A Offering Registration Statement
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1 Offering Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. UPLOAD Other SEC-generated Letter

Page 1 of 1 · 20 filings